Eastgate Biotech Corp Performance
| ETBIDelisted Stock | USD 0 0.00 0.00% |
The firm shows a Beta (market volatility) of -45.73, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Eastgate Biotech are expected to decrease by larger amounts. On the other hand, during market turmoil, Eastgate Biotech is expected to outperform it. Eastgate Biotech Corp right now shows a risk of 0.0%. Please confirm Eastgate Biotech Corp treynor ratio and rate of daily change , to decide if Eastgate Biotech Corp will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Eastgate Biotech Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental drivers, Eastgate Biotech is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
Eastgate |
Eastgate Biotech Relative Risk vs. Return Landscape
If you would invest 0.45 in Eastgate Biotech Corp on September 12, 2024 and sell it today you would earn a total of 0.00 from holding Eastgate Biotech Corp or generate 0.0% return on investment over 90 days. Eastgate Biotech Corp is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Eastgate, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Eastgate Biotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eastgate Biotech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Eastgate Biotech Corp, and traders can use it to determine the average amount a Eastgate Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ETBI |
Based on monthly moving average Eastgate Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eastgate Biotech by adding Eastgate Biotech to a well-diversified portfolio.
Eastgate Biotech Fundamentals Growth
Eastgate Stock prices reflect investors' perceptions of the future prospects and financial health of Eastgate Biotech, and Eastgate Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Eastgate Stock performance.
| Operating Margin | (74.40) % | |||
| Current Valuation | 18.92 M | |||
| Shares Outstanding | 2.06 B | |||
| Price To Earning | (0.10) X | |||
| Price To Sales | 1.49 X | |||
| EBITDA | (3.55 M) | |||
| Cash And Equivalents | 4.91 K | |||
| Total Debt | 1.67 M | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (389.48 K) | |||
| Earnings Per Share | (0.01) X | |||
| Retained Earnings | (14.63 M) | |||
| Current Asset | 167 K | |||
| Current Liabilities | 2.11 M |
About Eastgate Biotech Performance
By evaluating Eastgate Biotech's fundamental ratios, stakeholders can gain valuable insights into Eastgate Biotech's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Eastgate Biotech has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Eastgate Biotech has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. Eastgate Biotech Corp. was founded in 1999 and is based in Toronto, Canada. EASTGATE BIOTECH is traded on OTC Exchange in the United States.Things to note about Eastgate Biotech Corp performance evaluation
Checking the ongoing alerts about Eastgate Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Eastgate Biotech Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Eastgate Biotech is not yet fully synchronised with the market data | |
| Eastgate Biotech has some characteristics of a very speculative penny stock | |
| Eastgate Biotech has a very high chance of going through financial distress in the upcoming years | |
| Eastgate Biotech Corp currently holds 1.67 M in liabilities. Eastgate Biotech Corp has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Eastgate Biotech's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (2.98 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Eastgate Biotech Corp currently holds about 4.91 K in cash with (389.48 K) of positive cash flow from operations. |
- Analyzing Eastgate Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Eastgate Biotech's stock is overvalued or undervalued compared to its peers.
- Examining Eastgate Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Eastgate Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Eastgate Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Eastgate Biotech's stock. These opinions can provide insight into Eastgate Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Eastgate Stock
If you are still planning to invest in Eastgate Biotech Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eastgate Biotech's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |